Skip to content
10-Q

Quarterly Report

VitaNova Life Sciences Corporation VNOV

0001683168-24-008711

← back to feed
Filed
Dec 13, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Dec 12, 2024 25.01M sh
Current Liabilities Q2 2025 · Oct 31, 2024 $223.94K
Current Liabilities Q2 2025 · Apr 30, 2024 $136.92K
Total Liabilities Q2 2025 · Oct 31, 2024 $223.94K
Total Liabilities Q2 2025 · Apr 30, 2024 $136.92K
Current Assets Q2 2025 · Oct 31, 2024 $1.26M
Current Assets Q2 2025 · Apr 30, 2024 $1.19M
Total Assets Q2 2025 · Oct 31, 2024 $1.26M
Total Assets Q2 2025 · Apr 30, 2024 $1.19M
Shares Diluted Q2 2025 · Oct 31, 2023 5.87M sh
Shares Diluted Q2 2025 · Oct 31, 2023 5.87M sh
Operating Cash Flow Q2 2025 · Oct 31, 2023 −$34.14K
Stockholders Equity Q2 2025 · Oct 31, 2023 −$92.22K
Stockholders Equity Q2 2025 · Jul 31, 2023 −$83.46K
Stockholders Equity Q2 2025 · Apr 30, 2023 −$59.22K
Eps Diluted Q2 2025 · Oct 31, 2023 $0.00
Eps Diluted Q2 2025 · Oct 31, 2023 −$0.01
Eps Basic Q2 2025 · Oct 31, 2023 $0.00
Eps Basic Q2 2025 · Oct 31, 2023 −$0.01
Sga Expense Q2 2025 · Oct 31, 2023 $8.76K
Sga Expense Q2 2025 · Oct 31, 2023 $33K
Net Income Q2 2025 · Oct 31, 2023 −$8.76K
Net Income Q2 2025 · Oct 31, 2023 −$33K
Net Income Q2 2025 · Jul 31, 2023 −$24.25K
Operating Income Q2 2025 · Oct 31, 2023 −$8.76K
Operating Income Q2 2025 · Oct 31, 2023 −$33K
Gross Profit Q2 2025 · Oct 31, 2023 $0
Gross Profit Q2 2025 · Oct 31, 2023 $0
Cost Of Revenue Q2 2025 · Oct 31, 2023 $0
Cost Of Revenue Q2 2025 · Oct 31, 2023 $0
Revenue Q2 2025 · Oct 31, 2023 $0
Revenue Q2 2025 · Oct 31, 2023 $0